English | 繁體

Search in the results

UM

Browse/Search Results:  1-6 of 6 Help

Selected(0)Clear Items/Page:    Sort:
An insulin growth factor-I/II-neutralizing monoclonal antibody in combination with epidermal growth factor receptor inhibitors potently inhibits tumor cell growth Journal article
Ma, Guofang, Tan, Chengyue, Shan, Yaming, Shao, Ningyi, Wang, Feng, Dimitrov, Dimiter S., Wang, Liping, Zhao, Qi. An insulin growth factor-I/II-neutralizing monoclonal antibody in combination with epidermal growth factor receptor inhibitors potently inhibits tumor cell growth[J]. Journal of Cancer, 2022, 13(5), 1830-1836.
Authors:  Ma, Guofang;  Tan, Chengyue;  Shan, Yaming;  Shao, Ningyi;  Wang, Feng; et al.
Favorite | TC[WOS]:4 TC[Scopus]:4  IF:3.3/3.3 | Submit date：2022/05/17
Egfr  Gefitinib  Igf-i  Igf-ii  M708.5  Monoclonal Antibody  
Black phosphorus nanoparticles for dual therapy of non-small cell lung cancer Journal article
Lin, Zhongxiao, Deng, Qiudi, Fang, Qi, Li, Xinzhi, Liu, Xiaoyan, Wang, Jianglin, Chen, Sheng, Huang, Xiaotao, Yang, Langyu, Miao, Yingling, Yu, Xi Yong. Black phosphorus nanoparticles for dual therapy of non-small cell lung cancer[J]. Journal of Drug Targeting, 2022, 30(6), 614-622.
Authors:  Lin, Zhongxiao;  Deng, Qiudi;  Fang, Qi;  Li, Xinzhi;  Liu, Xiaoyan; et al.
Favorite | TC[WOS]:7 TC[Scopus]:4  IF:4.3/4.6 | Submit date：2023/01/30
Black Phosphorus  Gefitinib  Lung Cancer  Photothermal Therapy  Targeted Therapy  
CuS Nanoparticles as a Photodynamic Nanoswitch for Abrogating Bypass Signaling To Overcome Gefitinib Resistance Journal article
Xiajing Gu, Yuanyuan Qiu, Miao Lin, Kai Cui, Gaoxian Chen, Yingzhi Chen, Chenchen Fan, Yongming Zhang, Lu Xu, Hongzhuan Chen, Jian-Bo Wan, Wei Lu, Zeyu Xiao. CuS Nanoparticles as a Photodynamic Nanoswitch for Abrogating Bypass Signaling To Overcome Gefitinib Resistance[J]. NANO LETTERS, 2019, 19(5), 3344-3352.
Authors:  Xiajing Gu;  Yuanyuan Qiu;  Miao Lin;  Kai Cui;  Gaoxian Chen; et al.
Favorite | TC[WOS]:42 TC[Scopus]:44  IF:9.6/10.1 | Submit date：2020/04/22
Gefitinib  Cus Nanoparticles  Non-small Cell Lung Cancer  Rug Resistance  Active Oxygen Species  
Autophagic degradation of epidermal growth factor receptor in gefitinib-resistant lung cancer by celastrol Journal article
Xu S.-W., Law B.Y.K., Mok S.W.F., Leung E.L.H., Fan X.X., Coghi P.S., Zeng W., Leung C.-H., Ma D.-L., Liu L., Wong V.K.W.. Autophagic degradation of epidermal growth factor receptor in gefitinib-resistant lung cancer by celastrol[J]. International Journal of Oncology, 2016, 49(4), 1576-1588.
Authors:  Xu S.-W.;  Law B.Y.K.;  Mok S.W.F.;  Leung E.L.H.;  Fan X.X.; et al.
Favorite | TC[WOS]:26 TC[Scopus]:29 | Submit date：2018/11/06
Autophagy  Calcium  Celastrol  Epidermal Growth Factor Receptor  Gefitinib-resistant Lung Cancer  
Anti-cancer synergy of dichloroacetate and EGFR tyrosine kinase inhibitors in NSCLC cell lines Journal article
Yang,Zheng, Tam,Kin Y.. Anti-cancer synergy of dichloroacetate and EGFR tyrosine kinase inhibitors in NSCLC cell lines[J]. European Journal of Pharmacology, 2016, 789, 458-467.
Authors:  Yang,Zheng;  Tam,Kin Y.
Favorite | TC[WOS]:31 TC[Scopus]:31  IF:4.2/4.3 | Submit date：2021/03/04
Dichloroacetate  Drug Combination  Epidermal Growth Factor Receptor  Erlotinib  Gefitinib  Pyruvate Dehydrogenase Kinase  
Anti-cancer synergy of dichloroacetate and EGFR tyrosine kinase inhibitors in NSCLC cell lines Journal article
Yang Z., Tam K.Y.. Anti-cancer synergy of dichloroacetate and EGFR tyrosine kinase inhibitors in NSCLC cell lines[J]. European Journal of Pharmacology, 2016, 789, 458-467.
Authors:  Yang Z.;  Tam K.Y.
Favorite | TC[WOS]:31 TC[Scopus]:31 | Submit date：2018/12/18
Dichloroacetate  Drug Combination  Epidermal Growth Factor Receptor  Erlotinib  Gefitinib  Pyruvate Dehydrogenase Kinase